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Abstract
Whether widespread use of HAART changed patterns of HIV status disclosure among women 
living with HIV is largely unknown. In addition, the association between time to first HIV 
disclosure and depression has not been fully explored among women. A retrospective cross-
sectional survey was conducted among HIV-infected women from the Washington, DC site of the 
Women’s Interagency HIV Study to collect detailed information about their HIV status disclosure 
behavior. A sample of 202 HIV-positive women, 102 diagnosed prior to and 100 post-HAART era 
participated in this study. Relationships between treatment era when diagnosed (pre-HAART or 
HAART era) and patterns of HIV status disclosure, and associations between HIV status 
disclosure and depression level were examined using generalized linear regression models with 
generalized estimating equation to adjust for repeated measurements from the same individuals. 
Our analyses showed that treatment era was not associated with either comfort level of HIV status 
disclosure or time to first HIV disclosure to either family members or friends. However, women 
were less likely to disclose HIV status to their family members in the HAART era (P = 0.006) 
after adjusting for social network type, comfort level of disclosure, time to first disclosure and 
length of follow-up time. In addition, longer time to first HIV disclosure, but not comfort level or 
extent of HIV status disclosure, was independently associated with depression levels as measured 
by CES-D score at study enrollment (“a few months after” vs “within a few days”: P = 0.008). 
More definitive studies utilizing longitudinal designs should be conducted to further examine 
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impact of HAART era on HIV status disclosure and effect of HIV status disclosure on mental 
health.
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Introduction
Disclosure of HIV-positive status may be a stressful event. For women living with HIV, the 
decision to disclose their serostatus involves evaluation of potential benefits and risks. 
Research has shown that over time people living with HIV typically disclose to different 
social network groups, such as family members, friends, sexual partners and health care 
professionals (Sowell, Seals, Phillips, & Julious, 2003). The prevalence of HIV status 
disclosure among women reported in the existing literature varies substantially. For instance, 
a systematic review of studies in developing countries reported prevalence of HIV status 
disclosure ranging from 16.7% to 86.0% (Medley, Garcia-Moreno, McGill, & Maman, 
2004). Another study in Zimbabwe found that prevalence of disclosure ranged from 19% to 
78%. The reception of disclosure was positive in most cases, with rates ranging from 72% to 
95% (Patel et al., 2012). However, disclosure remains difficult for some individuals (Sowell 
et al., 2003); between 3.5% of women in Kenya and 14.6% in Tanzonia reported 
experiencing a violent reaction from a partner following disclosure (Medley et al., 2004).
Studies have shown that many factors may independently affect HIV status disclosure. 
Significant positive predictors of HIV disclosure for women include motherhood 
(Iwelunmor, Zungu, & Airhihenbuwa, 2010), older age (Ross, Stidham, & Drew, 2012), 
employment (Ross et al., 2012), being married (Patel et al., 2012), and social support 
(Kalichman, DiMarco, Austin, Luke, & DiFonzo, 2003; Rice, Comulada, Green, Arnold, & 
Rotheram-Borus, 2009; Ross et al., 2012). Factors impeding disclosure of HIV status 
include perceived negative consequences of disclosure (Kalichman et al., 2003) and not 
receiving antiretroviral treatment (Menon, Glazebrook, Campain, & Ngoma, 2007). The 
widespread use of highly active antiretroviral therapy (HAART) since 1996 has turned the 
HIV/AIDS from a disease of high mortality to one that can be managed through medication. 
Research has begun to explore the impact of HAART era on HIV disclosure patterns; so far, 
two qualitative studies have shown somewhat contradictory results (Klitzman et al., 2004)
(Siegel, Lekas, & Schrimshaw, 2005). Klitzman et al (Klitzman et al., 2004) identified 
several avenues through which the use of HAART affects patterns of HIV disclosure. 
HAART allows some individuals to refrain from or delay disclosing through retaining their 
pre-infection physical appearance and ability to “pass” as HIV-negative. Moreover, HAART 
can lead to unintentional disclosure if individuals are seen taking the medication. Siegel et 
al. compared factors related to disclosure among women diagnosed pre- and in the HAART 
era (Siegel, Lekas, & Schrimshaw, 2005), and found participants’ beliefs about disclosure 
did not differ by treatment eras. Further investigation is needed to clarify the effect of 
HAART on HIV disclosure.
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Research has investigated the relationship between HIV disclosure and mental health among 
women and the results seem to be consistent. Menon et al showed that disclosure of HIV 
status did not have a negative effect on mental health (Menon et al., 2007). Patel et al 
reported that believing in the positive consequences of disclosure was related to fewer 
depressive symptoms (Patel et al., 2012). Vyavaharkar et al. revealed that total number of 
disclosures was inversely correlated with depression (Vyavaharkar et al., 2011). However, no 
study was conducted to examine time to first disclosure on mental health.
In this study, we examined associations between treatment era at enrollment (pre-HAART or 
HAART era) and HIV status disclosure patterns, and associations between disclosure 
patterns and depression level in a cohort of women living with HIV at the DC site of the 
Women’s Interagency HIV Study (WIHS).
Methods
Women’s Interagency HIV Study
WIHS is an ongoing cohort study focusing on women’s natural and treated history of HIV/
AIDS (Bacon et al., 2005; Barkan et al., 1998). Two thousand eight hundred and thirteen 
(2,813) women living with HIV and 953 HIV-negative at-risk women were enrolled during 
three phases, 1994–1995, 2000–2001 and 2010–2011 in 6 regions, including Chicago; the 
San Francisco Bay Area; Brooklyn and the Bronx in New York City; and the Washington 
DC and Los Angeles metropolitan areas. Data have been collected through participant 
interviews approximately every 6 months. The data collected include sociodemographic 
characteristics, substance use, sexual behaviors, HIV treatment and clinical manifestations. 
Biomedical samples are also collected and stored for future use. Informed consent was 
obtained from each participant and the study proposal was approved by local institutional 
review boards. For this study, 202 women living with HIV from the Washington DC site of 
the WIHS were interviewed at one visit between Oct 1, 2011 and Sep 30, 2012 to investigate 
their HIV status disclosure behaviors.
HIV status disclosure questionnaire
Questions about patterns of HIV status disclosure covered three aspects: (1) comfort level in 
disclosure of sexually transmitted diseases such as HIV, (2) time to first HIV status 
disclosure, and (3) extent of HIV status disclosure to social networks. The survey included 
questions about social network groups including family members, friends, main sexual 
partner (i.e. husband/boyfriend/main partner), casual sexual partners, church members and 
others. Preliminary data exploration showed relatively small sample size for casual partners, 
church members and others groups. Some questions asked information about main sexual 
partners, while others combined main sexual partners into family members group. Thus, for 
consistency, main sexual partners were combined into the family member group for all 
analyses, and our analyses focused on the two major groups: family members and friends.
Comfort level of disclosure to social network
Questions such as “How comfortable is it for you to disclose a sexually transmitted disease 
(STD) such as HIV to a family member?” were asked. Responses included (1) very 
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comfortable; (2) comfortable; (3) somewhat comfortable; and (4) not comfortable. Identical 
questions were asked for other social network groups;
HIV status disclosure to the very first person
Questions asked included “Who was the very first person to whom you disclosed?” and 
“When did disclosure occur”. Time from HIV diagnosis to first HIV status disclosure was 
categorized into 3 exclusive categories: (1) within a few days; (2) a few weeks after; (3) a 
few months after.
Extent of HIV status disclosure to social network
A set of questions on extent of HIV status disclosure were asked with regard to different 
social network groups. For instance, for family members, the questions included “How many 
of your family members have you told that you are HIV-positive?” Responses included (1) 
all or nearly all, (2) most of them, (3) about half, (4) some of them, (5) very few and (6) 
none.
Depression measurement scale
Depression was assessed at study enrollments using the Centers for Epidemiological Studies 
Depression Scale (CES-D) (Radloff, 1977). The CES-D scores range from zero to sixty, with 
higher scores indicating a higher frequency of depressive symptoms during the last week.
Variable definitions
Our study consisted of two sets of analyses: (1) Association between treatment era at 
enrollment and HIV status disclosure patterns. For this set of analyses, the study outcomes 
were patterns of HIV status disclosure, including comfort level of disclosure, time to first 
disclosure, and extent of disclosure to social network groups. The exposure variable was 
treatment era at study enrollment: pre-HAART (<1996) or HAART era (≥1996). Covariates 
included types of social network group and disclosure target characteristics such as gender; 
(2) Association between HIV status disclosure patterns and CES-D score at study 
enrollment. For this set of analyses, the CES-D was used as a continuous variable in order to 
increase study power. The exposure variables included comfort level of HIV status 
disclosure, time to first disclosure, and extent of disclosure to the social network groups. 
Covariates were selected because of their potential associations with CES-D score and HIV 
status disclosure, including race (White, African-American, Hispanic and Others), age, 
income ($12000+ or not), education (less than high school, completed high school, and 
above high school), quality of life score (measured on a scale from 0 to 100 using a modified 
SF-36 form) (Bozzette, Hays, Berry, Kanouse, & Wu, 1995), CD4+ T cell counts and HIV 
viral load at study enrollment.
Statistical analysis
Analysis of variance was used to assess mean differences for continuous variables, and Chi-
square tests were used to examine proportion differences for categorical variables. 
Generalized linear model with generalized estimating equation was used to explore the 
quantitative relationship between outcome variables and main exposure variables after 
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adjusting for repeated measurements from the same individual (Hardin & Hilbe, 2003). We 
examined univariate associations first and only variables with significant univariate 
associations were included in the multivariate analyses. Estimated statistics and their 
corresponding 95% confidence intervals were used to assess magnitude and range of the 
associations. All analyses were carried out using SAS 9.3 (Cary, NC).
Results
Participant characteristics at study enrollment
The participants had a mean age of 36 years (Table 1), and the majority of the sample was 
African-American (76.7%). Among all participants, only 45% had education levels above 
high school, and about 39% had annual income less than $12,000. At the enrollment, the 
mean CD4+ T cell counts was 477 cells/ml, the mean HIV RNA level (log10) was 3.6, the 
mean quality of life score was 68.7 and the mean CES-D score was 15.2. Comparing to the 
pre-HAART group, the HAART group had more African-Americans and lower HIV RNA 
level.
Association between HAART era and HIV status disclosure to social network groups
1. Comfort level with disclosure of STD status: comparing comfort levels of 
disclosing STD such as HIV between the pre-HAART and HAART groups, no 
significant difference was observed for disclosure to either family members or 
friends groups (see Table 2).
2. Time to first HIV status disclosure: After diagnosis, 77% of the participants 
chose a family member or relative as their very first person to disclose HIV 
status. Among family members, mother, sisters, and husband/boyfriend/main 
partner were the most frequent persons to whom participants first disclosed. 
About 60% of the women first disclosed their HIV status to females. No 
difference was found in the distributions of first HIV disclosure to different 
genders between the treatment eras (see Table 2). The majority of participants 
disclosed their status within a few days (see Table 2). For both family and friend 
groups, no significant difference was observed in comparing time to first HIV 
status disclosure between the treatment eras (see Table 2).
3. Disclosure level to social networks: The overall disclosure levels to family 
members and friends can be found in Table 2. About 61% and 30% of 
participants reported disclosure of their HIV status to all/most family members 
or friends respectively. Comparing disclosure level between the treatment eras, a 
significant difference was observed for family members, with women disclosing 
more in the pre-HAART era (P = 0.010, see Table 2); this difference was not 
observed for the friend group. To further examine whether the association 
between treatment era at enrollment and extent of HIV status disclosure is 
independent from other risk factors, a multivariate analysis was carried out, with 
social network type (family vs friend), comfort level of disclosure, time to first 
disclosure and length of follow up time being the covariates. Our results showed 
that treatment era at enrollment remained significantly associated with extent of 
Liu et al. Page 5
AIDS Care. Author manuscript; available in PMC 2018 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
HIV status disclosure to family members (P = 0.006) even after adjusting for 
these covariates.
Association between patterns of HIV status disclosure and CES-D score
We examined the associations between different HIV disclosure variables, as well as a 
number of covariates, with CES-D score at the study enrollment. Univariately, comfort level 
of disclosure and extent of disclosure to social network were not associated with CES-D. 
However, an association between time to first HIV status disclosure and CES-D score was 
found (see Table 3). Participants who disclosed their HIV positive status sooner had lower 
CES-D scores (“a few months after” vs “within a few days”, P = 0.008). In the multivariate 
model, time to first disclosure of HIV status remained significantly associated with CES-D 
score (“a few months after” vs “within a few days”, P = 0.008) after adjusting for those 
covariates (income level, HIV RNA level and QOL) significant in univariate analysis.
Discussion
For individuals living with HIV, the decision about to whom and when they will first 
disclose HIV status is an important one. The patterns of disclosure to different social 
network groups have been shown to depend on the perceptions of how much support 
individuals in that group will provide. For instance, Maman et al. found that early disclosure 
to one family member was motivated by the high value they placed on family support. 
Others found that individuals living with HIV disclosed more often to the groups they 
perceived more support from (Kalichman et al., 2003)(Zea, Reisen, Poppen, Bianchi, & 
Echeverry, 2007; Zea, Reisen, Poppen, Echeverry, & Bianchi, 2004). In this study, we did 
not ask women about their reasons for disclosing HIV status, but our results suggest that 
they disclosed to their mother and sisters more often than to their father and brothers, which 
is consistent with previous studies (Kalichman et al., 2003; Maman, van Rooyen, & Groves, 
2013).
Our study observed that participants diagnosed in the HAART era were less likely to 
disclose their HIV status to their family members even after adjusting for length of follow-
up time. Two possible explanations are: (1). women diagnosed after HAART became 
available do not believe they are at risk of impending death due to HAART’s proven 
effectiveness and they may not see disclosure as an urgent necessity; (2). the HIV-infected 
women may be delaying disclosure to family members because they believe HAART has 
effectively prevented external signs of HIV infection in their appearance (Kalichman et al., 
2003).
Studies have shown that positive beliefs regarding disclosure or overall level of HIV status 
disclosure was significantly correlated with fewer depressive symptoms among women 
(Patel et al., 2012) (Vyavaharkar et al., 2011; Woodward & Pantalone, 2012). We did not 
find evidence of a relationship between CES-D score and comfort level with or extent of 
HIV status disclosure. However, we did find that individuals who delayed initial disclosure 
were more likely to report higher CES-D score. Possible reasons for this inconsistency 
between our findings and earlier studies may lie in geodemographical difference of the study 
populations and then different levels of perceived social support.
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Comparing to previous studies, our study has some strengths. First, our study might be the 
only quantitative study that examined the association between HAART availability and HIV 
disclosure patterns thus far; Second but not last, to our best knowledge, our study might be 
the first study to examine the association between time to initial HIV status disclosure and 
depression level among women. However, our study has some limitations too. First, we used 
a retrospective cross-sectional survey, in which women were asked to recall circumstances of 
HIV status disclosure that occurred years earlier and information collected might be subject 
to recall and memory bias. However, given the salience of HIV disclosure, the recall bias 
might be minimal as many participants could still report it vividly after many years. Second, 
temporal ambiguity between disclosure and CES-D score at study enrollment might be an 
issue to consider because we could not ascertain with clarity the temporal relationship 
between HIV status disclosure and depression measurement at study enrollment. However, 
given that all women in this study were HIV positive already at study enrollment and the 
majority of disclosure happened within a few days after HIV diagnosis, the impact of this 
issue might be minimal. Lastly, we grouped the main sexual partners into family member 
group in our analyses and some might doubt that the disclosure patterns to main sexual 
partners might be different from those to other family members. However, we did separate 
analyses for those questions where main sexual partners were asked separately from other 
family members, and found the examined association remained the same with and without 
main sexual partners included into the family group (data not shown).
The findings that women who enrolled in the HAART era are less likely to disclose their 
HIV status to family members and that those who disclosed more quickly reported lower 
depression score may have implications for interventions for women who have been newly 
diagnosed as HIV-positive. More definitive studies should be conducted utilizing 
longitudinal designs that clearly delineate the temporal order of HIV diagnosis, initial 
disclosure, and depression.
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Table 1
Characteristics of Study Participants at Study Enrollment
Characteristic Variables Total (N = 202) Pre- HAART Group (n1=102) HAART Group (n2 = 100) P - value
Age, mean (SD) 36.0(8.4) 35.0(7.4) 36.9(9.2) 0.113
Race, % 0.008
 White 14.9 22.5 7.0
 African-American 76.7 69.6 84.0
 Hispanic and others 8.4 7.8 9.0
Education, % 0.315
 Less than high school 22.0 26.5 18.2
 Complete high school 32.3 32.3 32.3
 Above high school 45.0 41.2 49.4
Income less than $12,000 per year, % 39.4 37.0 42.0 0.480
CES-D score, mean (SD) 15.2(11.8) 15.8(11.2) 14.5(12.5) 0.456
CD4+ T cell counts, mean (SD) 477.0(304) 488.0(314) 465.0(293) 0.588
Log10 of HIV RNA, mean (SD) 3.6(1.2) 3.9(1.0) 3.4(1.3) 0.003
Quality of life, mean (SD) 68.7(20.3) 67.1(19.7) 70.7(20.9) 0.230
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Table 2
HIV Status Disclosure Patterns in Pre-HAART and HAART Groups
HIV Status Disclosure Patterns Overall(N=202)
Pre- HAART Group
(n1=102)
HAART Group
(n2=100) P- value
Comfort level of disclosure
 A family member or relative, % 0.368
  Very comfortable 34.5 39.2 30.0
  Comfortable 18.8 14.4 23.0
  Somewhat comfortable 17.3 17.5 17.0
  Not comfortable 29.4 28.9 30.0
 A friend, % 0.067
  Very comfortable 17.2 20.9 13.7
  Comfortable 18.3 19.8 16.8
  Somewhat comfortable 25.3 29.7 21.0
  Not comfortable 39.3 29.7 48.4
First person to disclose
 A family member or relative, % 0.170
  Female 60.0 63.8 56.9
  Male 40.0 36.2 43.1
 A friend, % 0.103
  Female 62.5 75 50.0
  Male 37.5 25 50.0
Time to first disclosure
 A family member or relative, % 0.564
  Within a few days 72.7 75 70.0
  A few weeks after 6.3 4.2 8.5
  A few months after 21.0 20.8 21.1
 A friend, %
  Within a few days 81.1 66.7 94.7 0.089
  A few weeks after 2.7 100 0
  A few months after 16.2 27.8 5.3
Extent of HIV Status Disclosure to Social Network Groups
 Family member or relative %
  All or nearly all 43.2 52.0 34.0 0.010
  Most of them 17.8 17.0 18.6
  About half 7.6 2.0 13.4
  Some of them 6.1 8.0 4.1
  Very few 14.7 13.0 16.5
  None 10.7 8.0 13.4
 Current Friends, % 0.139
  All or nearly all 18.1 21.0 15.0
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HIV Status Disclosure Patterns Overall(N=202)
Pre- HAART Group
(n1=102)
HAART Group
(n2=100) P- value
  Most of them 12.6 16.0 9.0
  About half 5.0 4.0 6.0
  Some of them 11.1 14.0 8.0
  Very few 32.7 30.0 35.4
  None 20.6 15.0 26.3
Note: due to missing data, the data within each category may not add up to one hundred percent.
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Table 3
Association between HIV Status Disclosure and Depression at Study Enrollment
Univariate Multivariate
Independent variables Parameter P-value Parameter P-value
Main exposures
Comfort level
 Not comfortable 3.6237 0.062
 Somewhat Comfortable 1.2402 0.516
 Comfortable 0.8221 0.705
 Very comfortable 0
Time to first disclosure
 A few months after 5.796 0.008 4.687 0.008
 A few weeks after 9.986 0.010 2.687 0.447
 within a few days 0 0
Extent of disclosure to social network
 None −0.0396 0.985
 Very few 0.644 0.728
 Some of them 2.4244 0.407
 About half −1.2615 0.609
 Most of them 0.2018 0.920
 All or nearly all 0
Age −0.091 0.363
Education
 Lower than high school 0
 Completed high school −0.179 0.938
 Above high school −3.711 0.086
Income $12000 or less 5.808 <0.001 2.659 0.077
Enrollment waves
 Pre- HAART 1.249 0.456
 Post- HAART 0
Log10 (HIV RNA level) −1.414 0.046 −1.568 0.011
Quality of life −0.384 <.001 −0.348 <.001
Note: covariates adjusted for in the multivariate model include income level, Log10(HIV RNA level) and Quality of life.
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